Adverse Drug Events (ADE)

Adverse Drug Events (ADE) / en Sat, 26 Apr 2025 19:00:47 -0500 Fri, 20 Sep 24 14:02:31 -0500 CDC data show 10% drop in overdose deaths this year /news/headline/2024-09-20-cdc-data-show-10-drop-overdose-deaths-year Drug overdose deaths have dropped by 10% this year compared to last, according to <a href="https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm">data</a> from the Centers for Disease Control and Prevention. This year also marked an annual decline in overdose deaths for the first time in five years. On Aug. 31, federal agencies <a href="/news/headline/2023-09-05-agencies-award-grants-help-address-drug-overdose-crisis">awarded</a> an additional $416 million to respond to the overdose crisis and support substance use treatment and recovery services. The AHA remains focused on supporting hospitals and health systems in reducing drug overdose deaths, including by providing resources to enhance opioid stewardship. Learn more from <a href="/opioids">AHA’s Opioid Stewardship Hub</a>.&nbsp; Fri, 20 Sep 2024 14:02:31 -0500 Adverse Drug Events (ADE) CDC investigating counterfeit, mishandled botulinum toxin injections /news/headline/2024-04-23-cdc-investigating-counterfeit-mishandled-botulinum-toxin-injections The Centers for Disease Control and Prevention and Food and Drug Administration are investigating adverse effects in 22 people in 11 states who received botulinum toxin injections that were counterfeit or administered in non-healthcare settings or by unlicensed or untrained individuals. Eleven individuals were hospitalized. All but two of the injections were for cosmetic purposes. CDC <a href="https://emergency.cdc.gov/han/2024/han00507.asp">said</a> clinicians should consider the possibility of adverse effects from botulinum toxin injections in patients presenting with localized paralysis and immediately contact their state or local health department if they suspect botulism, a rare and sometimes fatal illness caused by botulinum toxin.&nbsp; Tue, 23 Apr 2024 15:16:00 -0500 Adverse Drug Events (ADE) FDA announces voluntary tetracycline recall /news/headline/2020-04-22-fda-announces-voluntary-tetracycline-recall The Food and Drug Administration <a href="https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/avet-pharmaceuticals-inc-issues-voluntary-nationwide-recall-tetracycline-hcl-capsules-usp-250-mg-and">recently announced</a> that Avet Pharmaceuticals Inc. issued a voluntary recall of the antibiotic, tetracycline, specifically, Tetracycline HCl Capsules USP, 250 mg and 500 mg, distributed under the Heritage Pharmaceuticals Inc. label. The drug maker reports that the affected products experience a low dissolution, resulting in less tetracycline in the body to combat infection. As a result, patients with compromised immune systems and the elderly, who may be taking tetracycline to treat a serious infection such as pneumonia, may experience rapid progression of infections or death. Wed, 22 Apr 2020 16:01:14 -0500 Adverse Drug Events (ADE)